NITI Aayog roadmap targets $691 bn bioeconomy by 2035: Singh

India's bioeconomy could expand to USD 691 billion by 2035, generate more than 30 million high-value jobs and position the country among the world's top three biotechnology powers, according to a roadmap unveiled by NITI Aayog on Thursday. Union Minister Dr Jitendra Singh said India is ready to lead the next wave of biotechnology-driven growth.
According to agency reports,launching the Roadmap for Building India as a Leading Bioeconomy Powerhouse by 2035, Singh said biotechnology is driving the "fourth industrial revolution" and highlighted India's growing strength in the sector."The fourth industrial revolution is being driven by biotechnology," the minister said, noting that the global bioeconomy market is currently valued at USD 1.4-1.8 trillion, while India is home to more than 11,000 biotechnology startups."We are among the very few countries that have come out with a dedicated biotechnology policy," Singh said, adding, "We are no longer waiting for others to experiment. We are ready to take risks and take risks with a certain amount of confidence.

We are among the very few countries that have come out with a dedicated biotechnology policy.

Our pace of progress has also accelerated significantly. In 2014, India had only a few hundred biotech startups. Today, that number has grown to over 11,000, with many of them… pic.twitter.com/eASNawPzP8

— PIB India (@PIB_India) July 16, 2026

The roadmap envisions India's bioeconomy expanding further to USD 2.6 trillion by 2047, contributing 8-10 per cent of GDP through a mission-driven strategy focused on biomanufacturing, AI-enabled biotechnology, regulatory reforms and stronger industry participation. It says India can emerge as one of the world's leading biotechnology hubs through sustained policy support and execution.To achieve these goals, the roadmap proposes six National BioMissions covering gene and cell therapies, climate-resilient agriculture, synthetic biology, disease surveillance, marine biotechnology and next-generation biopharmaceuticals.It also recommends establishing a Rs 50,000-crore BioEconomy Growth Fund for the 2026-2035 period to bridge the gap between laboratory research and commercial-scale manufacturing. Other measures include production-linked incentive (PLI)-style support, faster regulatory approvals and stronger intellectual property protection.Emphasising the importance of building domestic capabilities, Singh said developing skilled talent would be central to creating a self-reliant biotechnology ecosystem."We are introducing a course in engineering biology, which will be the first of its kind in India… which could be the key to bioeconomy," he said.
According to the roadmap, India's bioeconomy has already grown 16-fold, from USD 10 billion in 2014 to USD 195.3 billion in 2025, contributing 4.8 per cent to the country's GDP.
Summing up the long-term vision, Singh said a thriving bioeconomy would help India achieve multiple national objectives."Once we have a thriving bioeconomy, we will be addressing more than one national goal… there will be health security, food security, Vocal for Local and also global, there will be high-skill jobs in millions and above all the geopolitical stature of India," he said.